I C Endocrine Services Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 08152421 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2019

FOR

I C ENDOCRINE SERVICES LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

T A Cranston

I Cranston

REGISTERED OFFICE:

Fareham House

69 High Street

Fareham

Hampshire

PO16 7BB

REGISTERED NUMBER:

08152421 (England and Wales)

ACCOUNTANTS:

Wilkins Kennedy

Fareham House

69 High Street

Fareham

Hampshire

PO16 7BB

CURRENT ASSETS

Debtors

4

1,594

2,800

Cash at bank

27,804

-

29,398

2,800

CREDITORS

Amounts falling due within one year

5

10,030

2,524

NET CURRENT ASSETS

19,368

276

TOTAL ASSETS LESS CURRENT LIABILITIES

19,368

276

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

19,268

176

19,368

276

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 6th November 2019 and were signed on its behalf by:

I Cranston - Director

T A Cranston - Director

1.	STATUTORY INFORMATION

I C Endocrine Services Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty

Significant judgements and estimates

The preparation of financial statements often requires the use of judgements, estimates and assumptions that

affect the reported amounts of assets and liabilities at the date of the financial statements, and revenues and

expenses during the reporting period. These judgements, estimates and assumptions are based on

management's historical experience, knowledge and other factors including expectations of future events or

actions that are believed to be reasonable under the circumstances. Actual results may differ from those

amounts estimated.

In preparing these financial statements, management do not believe that they have made any critical

judgements in applying the company's accounting policies.

In preparing these financial statements, management do not believe that they have used any significant

estimates or assumptions.

Turnover

Turnover is measured at the fair value of the consideration received or receivable excluding discounts, rebates

and value added tax.

Revenue is recognised when there is a right to consideration.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the

balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws

that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal

of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2018 - 2 ) .

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Trade debtors

1,594

2,800

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Taxation and social security

8,654

1,494

Other creditors

1,376

1,030

10,030

2,524